STRO
Sutro Biopharma Inc

1,123
Mkt Cap
$338.9M
Volume
598,199.00
52W High
$26.54
52W Low
$5.23
PE Ratio
-0.80
STRO Fundamentals
Price
$20.68
Prev Close
$21.12
Open
$20.76
50D MA
$17.81
Beta
1.47
Avg. Volume
130,950.19
EPS (Annual)
-$29.61
P/B
-2.02
Rev/Employee
$183,559.17
$28.43
Loading...
Loading...
News
all
press releases
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Rating of "Hold" from Analysts
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given an average recommendation of "Hold" by the nine ratings firms that are presently covering the firm, MarketBeat reports. Two...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 19.8% in February
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) saw a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling 517,388 shares...
MarketBeat·7d ago
News Placeholder
Sutro Biopharma (STRO) to Release Quarterly Earnings on Thursday
Sutro Biopharma (NASDAQ:STRO) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat·17d ago
News Placeholder
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -11.71% and -49.91%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
174,843 Shares in Sutro Biopharma, Inc. $STRO Purchased by GSA Capital Partners LLP
GSA Capital Partners LLP purchased a new stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·20d ago
News Placeholder
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·1mo ago
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have been given a consensus rating of "Hold" by the nine brokerages that are currently covering the stock, Marketbeat reports. Two...
MarketBeat·2mo ago
News Placeholder
Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?
Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·2mo ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Raised to "Market Outperform" at Citizens Jmp
Citizens Jmp upgraded Sutro Biopharma from a "market perform" rating to a "market outperform" rating and set a $23.00 price objective for the company in a research note on Tuesday...
MarketBeat·2mo ago
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 27.8% in December
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totaling 404,777 shares...
MarketBeat·2mo ago
<
1
2
...
>

Latest STRO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.